Ionis Pharmaceuticals competitorsClear all

Ionis Pharmaceuticals's top competitors include Reata Pharmaceuticals, Arrowhead Pharmaceuticals, Alnylam Pharmaceuticals and Regulus Therapeutics.

Save Comparison	Ionis Pharmaceuticals Ionis Pharmaceuticals discovers and develops RNA-targeted therapeutics.	Reata Pharmaceuticals Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.	Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.	Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Founding Date	Founding Date 1989	Founding Date 2002	Founding Date 2004	Founding Date 2002	Founding Date 2007
Type	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development platform	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Carlsbad, US HQ	Locations Plano, US HQ Irving, US Plano, US	Locations Pasadena, US HQ Madison, US San Diego, US	Locations Cambridge, US HQ Paris, FR Milano, IT Amsterdam, NL Stockholm, SE Zug, CH Maidenhead, GB	Locations San Diego, US HQ
Employees	Employees 81711% increase	Employees 22079% increase	Employees 13416% increase	Employees 1,32324% increase	Employees 2462% decrease
Valuation ($)	Valuation ($) 6 b	Valuation ($) 3.5 b	Valuation ($) 6.6 b	Valuation ($) 16.7 b	Valuation ($) 100.1 m
Twitter followers	Twitter followers 3.3 k	Twitter followers 1.1 k	Twitter followers 2.6 k	Twitter followers 13.9 k	Twitter followers 789
Number of tweets (last 30 days)	Number of tweets (last 30 days) 15	Number of tweets (last 30 days) 21	Number of tweets (last 30 days) 8	Number of tweets (last 30 days) 20	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 12.7	Average likes per tweet (last 30 days) 5	Average likes per tweet (last 30 days) 41.9	Average likes per tweet (last 30 days) 10.2	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 95%	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 300164	Alexa Website Rank 264292	Alexa Website Rank 246863	Alexa Website Rank 365813	Alexa Website Rank 248055
Employee Rating	Employee Rating 3.5	Employee Rating 4.3	Employee Rating N/A	Employee Rating 4.3	Employee Rating 2.7
Financial
Revenue (est.)	Revenue (est.) $729.3m (FY, 2020)	Revenue (est.) $9m (FY, 2020)	Revenue (est.) $168.8m (FY, 2019)	Revenue (est.) $492.9m (FY, 2020)	Revenue (est.) $10m (FY, 2020)
Cost of goods	Cost of goods $11.9m (FY, 2020)	Cost of goods N/A	Cost of goods N/A	Cost of goods $78.1m (FY, 2020)	Cost of goods N/A
Gross profit	Gross profit $717.3m (FY, 2020)	Gross profit N/A	Gross profit N/A	Gross profit $414.8m (FY, 2020)	Gross profit N/A
Net income	Net income ($486.8m) (FY, 2020)	Net income ($247.8m) (FY, 2020)	Net income $68m (FY, 2019)	Net income ($858.3m) (FY, 2020)	Net income ($15.7m) (FY, 2020)
Operating ⚠
Patents Issued	Patents Issued N/A	Patents Issued 240 (FY, 2016)	Patents Issued 359 (FY, 2016)	Patents Issued N/A	Patents Issued 300 (FY, 2016)
Funding
Total funding raised	Total funding raised $ 201.3m	Total funding raised $ 468.9m	Total funding raised $ 147.1m	Total funding raised $ 1.5b	Total funding raised $ 10m